CompoAtlas

CURCUMA POIVRE

Food supplement declared in France, declaration No 2024-2-88, decision dated 2 February 2024

CURCUMA POIVRE (MAJELIS) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
MAJELIS
Food business operator placing the product on the market
SAS MAJELIS
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Gélule
Daily dose
1 gélule
Directions for use
1 gélule par jour.
Not recommended for (according to the manufacturer)
Adolescents (moins de 18 ans), Femmes allaitantes, Femmes enceintes, Sous anticoagulants
Objectives stated by the manufacturer (these are not authorised claims)
Articulations

Declaration 138792, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

None of the rules we check applies to the declared ingredients.

Declared composition

Plants

PlantPartPreparationPer day
Curcuma longa L.RhizomeAutre extrait sec150 mg
Piper nigrum L.FruitPoudre (de plantes séchées ou broyées)10 mg

Additives

Hydroxypropyl Méthyl Cellulose, E470b

Other ingredients

maltodextrine

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

List recorded in 2024. Photograph the packaging to check whether it has changed. Photograph the packaging

Label warnings

Ne pas consommer en cas d’obstruction ou d’autres troubles de la fonction biliaire. Déconseillé aux femmes enceintes ou allaitantes, en cas de traitements anticoagulants, immunosuppresseurs ou anticancéreux. Réservé à l’adulte.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Other declarations with the same name

This name is used by more than 10 declarations from different companies, so it does not identify one product. See every declaration with this name.

Brand : MAJELIS

List recorded in 2024. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line